OLINK HOLDING AB (PUBL) ADS news, videos and press releases
For more news please use our advanced search feature.
OLINK HOLDING AB (PUBL) ADS - More news...
OLINK HOLDING AB (PUBL) ADS - More news...
- Notice to attend the Extra General Meeting of Olink Holding AB (publ)
- Olink Announces Receipt of CMA Clearance for Proposed Acquisition by Thermo Fisher
- Report from the Extra General Meeting of Olink Holding AB (publ) on 5 July 2024
- Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker Discovery
- Notice to attend the Extra General Meeting of Olink Holding AB (publ)
- Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence
- Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis
- Olink reports first quarter 2024 financial results
- Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024
- Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease
- Olink publishes 2023 annual report
- Olink reports fourth quarter and full year 2023 financial results
- Notice to attend the Annual General Meeting of Olink Holding AB (publ)
- Olink announces change of date for Annual General Meeting
- Olink reports third quarter 2023 financial results
- Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics
- Landmark studies utilizing Olink® Explore technology signal a new era for population-scale proteogenomics
- Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.
- Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programs
- Olink to participate in September investor events
- Olink reports second quarter 2023 financial results
- Baylor College of Medicine Human Genome Sequencing Center adopts Olink® Explore HT proteomics platform
- Olink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth Conference
- Announcing Olink® Explore HT – A New Era in Proteomics
- Revealing the secrets of the human proteome with Olink® Insight: Exploring findings from one of the world's largest health studies
- Olink to participate in June investor events
- Olink reports first quarter 2023 financial results
- Report from the Annual General Meeting of Olink Holding AB (publ) on 17 April 2023
- Olink to report first quarter 2023 financial results on May 11, 2023
- Swedish Olink technology enables further development of South African research and innovation
